Full text 
Procedure : 2012/0035(COD)
Document stages in plenary
Document selected : A7-0015/2013

Texts tabled :


Debates :

PV 04/02/2013 - 20
CRE 04/02/2013 - 20

Votes :

PV 06/02/2013 - 5.3
CRE 06/02/2013 - 5.3
Explanations of votes

Texts adopted :


Monday, 4 February 2013 - Strasbourg

20. Transparency of measures regulating the prices of medicinal products for human use ***I (debate)
Verbatim reports

Report on the proposal for a directive of the European Parliament and of the Council relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems [COM(2012)0084 - C7-0056/2012- 2012/0035(COD)] - Committee on the Environment, Public Health and Food Safety. Rapporteur: Antonyia Parvanova (A7-0015/2013)

Antonyia Parvanova introduced the report.

The following spoke: Antonio Tajani (Vice-President of the Commission).

The following spoke: Cristian Silviu Buşoi (rapporteur for the opinion of the IMCO Committee), Zofija Mazej Kukovič, on behalf of the PPE Group, Nessa Childers, on behalf of the S&D Group, who also replied to a blue-card question by Paul Rübig, Alda Sousa, on behalf of the GUE/NGL Group, Françoise Grossetête and Andrés Perelló Rodríguez.

The following spoke under the 'catch-the-eye' procedure: Erik Bánki, Miroslav Mikolášik, Petru Constantin Luhan, Anna Záborská, Elena Băsescu, João Ferreira, Jaroslav Paška and Zbigniew Ziobro.

The following spoke: Antonio Tajani and Antonyia Parvanova.

The debate closed.

Vote: minutes of 6.2.2013, item 5.3.

Legal notice - Privacy policy